Medications for Opioid Use Disorder During Pregnancy: LIVE WEBINAR

25 Apr 2022
An evidence based/informed review of buprenorphine vs methadone during pregnancy and recommendations for providers/organizations that treat pregnant, postpartum, and reproductive age patients.
Presented by: Farzad Kamyar MD, MBA and Andria Peterson, PharmD
Continuing Education Units: 1 CEU
This training is approved for CEUs by the following professional organizations:
  • National Association of Alcohol & Drug Abuse Counselors (NAADAC)
  • National Board for Certified Counselors (NBCC)*
  • International Certification & Reciprocity Consortium (IC&RC)
*CASAT has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6492. Programs that do not qualify for NBCC credit are clearly identified. CASAT is solely responsible for all aspects of the programs.
  • Nevada Board of Examiners for Alcohol, Drug, & Gambling Counselors
  • Nevada State Board of Nursing
  • Board of Examiners for Marriage and Family Therapists and Clinical Professional Counselors
  • State of Nevada Board of Examiners for Social Workers
  • Nevada Certification Board - Approved for PRSS, CHW, & Prevention
Presentation materials are not for reproduction or distribution without specific written authorization.The opinions, findings, conclusions, and recommendations expressed in our courses are those of the author(s) and do not necessarily represent the official views of CASAT.


Date April 25, 2022 | 9:00 am PST
End Date April 25, 2022 | 10:00 am PST
Registration Start Date 02-28-2022 PST
Event Time Zone PST
Capacity 100
Spots Available 77
Cut Off Date April 25, 2022 | 8:30 am PST
Individual Price $20.00 Regular
$19.00 Licensed Pro
$10.00 Student/Intern/Retired
We are no longer accepting registration for this event
$20.00 77